Valneva SE (VALN)
9.00
+0.12
(+1.35%)
USD |
NASDAQ |
Dec 11, 15:32
Valneva EPS Diluted (Quarterly): -0.6036 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Innate Pharma SA | -- |
| Inventiva SA | -- |
| Nanobiotix SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.83M |
| Revenue (Quarterly) | 34.37M |
| Total Expenses (Quarterly) | 86.20M |
| Enterprise Value | 816.63M |
| Gross Profit Margin (Quarterly) | 18.71% |
| Profit Margin (Quarterly) | -150.8% |
| Earnings Yield | -15.23% |
| Normalized Earnings Yield | -15.23 |